Luke Wakeen to Ventricular Remodeling
This is a "connection" page, showing publications Luke Wakeen has written about Ventricular Remodeling.
Connection Strength
0.046
-
Jackson MR, Cox KD, Baugh SDP, Wakeen L, Rashad AA, Lam PYS, Polyak B, Jorns MS. Discovery of a first-in-class inhibitor of sulfide:quinone oxidoreductase that protects against adverse cardiac remodelling and heart failure. Cardiovasc Res. 2022 06 22; 118(7):1771-1784.
Score: 0.046